Trade Aurora Cannabis Inc ^ACB

Aurora Cannabis (TSE:ACB) Releases Quarterly Earnings Results - Stock Observer

Organigram (NASDAQ: OGI) agrees to buy Aurora at a 93% premium, topping Curaleaf - Daily Political

Aurora Cannabis Inc. (ACB) - What Are Investment Firms Saying About This Stock?

Aurora Cannabis (TSE:ACB) Rating Lowered to "Strong Sell" at TD Securities - Zolmax

Aurora Cannabis Inc. Q2 Loss Drops

Aurora Cannabis (NASDAQ:ACB) Rating Lowered to Strong Sell at TD Securities

Aurora Cannabis (TSE:ACB) Cut to Strong Sell at TD Securities - Markets Daily

Aurora Cannabis (TSE:ACB) Stock Rating Cut to "Strong Sell" at TD Securities - Stock Observer

Aurora Cannabis (ACB) Q2 2027 Earnings Date, Time & Estimates

Aurora Cannabis (TSE:ACB) Stock Gets Downgrade from TD

Cannabis Stocks To Keep An Eye On - November 4th - Stock Observer

Aurora Cannabis (TSE:ACB) Rating Lowered to Sell at TD - Daily Political

Organigram-Aurora $561 million deal taps Goodmans, Torys, Stikeman Elliott, Paul Weiss

Investors' concerns about the AI trade - BNN Bloomberg

Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis

Aurora Cannabis (TSE:ACB) Stock Price Up 19.9% - Time to Buy?

Organigram To Acquire Aurora Cannabis In C$561 Mln Deal

Organigram Swoops In To Acquire Aurora Cannabis, Topping Curaleaf's Rival Bid - ACB Stock Surges To Over 10-Month Highs

Organigram signs friendly deal to buy Aurora Cannabis after hostile Curaleaf offer

Organigram to Acquire Aurora and Establish a Global Cannabis Leader

Organigram Strikes A Deal to Acquire Aurora Cannabis

Canadian Investment Regulatory Organization Trade Resumption - ACB

Top Cannabis Stocks To Keep An Eye On - November 3rd - Stock Observer

Aurora Cannabis (TSE:ACB) Shares Climb 19.9% - Should You Buy? - Daily Political

Top Cannabis Stocks To Keep An Eye On - November 2nd - Stock Observer

Cannabis Stocks To Follow Today - October 31st - Markets Daily

Best Cannabis Stocks To Watch Today - October 29th - Daily Political

Cannabis Stocks To Follow Today - October 31st - Stock Observer

Best Cannabis Stocks To Follow Today - October 30th - Stock Observer

Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call

Aurora Cannabis (TSE:ACB) Stock Crosses Above Fifty Day Moving Average - Time to Sell?

Aurora Cannabis (TSE:ACB) Stock Price Up 5.8% - Still a Buy?

Aurora Cannabis (TSE:ACB) Share Price Breaks Above Fifty Day Moving Average - Here's Why - Daily Political

Top Cannabis Stocks To Consider - October 27th - Stock Observer

3 Canadian Healthcare Stocks With Revenue Growth Over 7%

Cannabis Stocks To Watch Now - October 22nd - Stock Observer

Aurora Cannabis (NASDAQ:ACB) & BioAge Labs (NASDAQ:BIOA) Head to Head Comparison - Stock Observer

Aurora Cannabis Rejects Curaleaf's Revised Takeover Offer

Promising Cannabis Stocks Worth Watching - October 20th - Daily Political

Top Cannabis Stocks To Keep An Eye On - October 19th - Daily Political

M&A News: Canada's Aurora Cannabis (ACB) Rejects Sweetened Takeover Offer

Curaleaf Criticizes Aurora Board Over Unequal Due Diligence Access

Cannabis Stocks To Follow Now - October 18th - Daily Political

Top 3 Canadian Healthcare Stocks To Watch In October 2026

Deal Dispatch: Ithaca Holdings Buys Bumble for $1.3B, The Knot Acquires Zola, Character.ai Bankruptcy

Surprised By Aurora Cannabis's Slide? What Investors Missed

Head to Head Contrast: BeOne Medicines (NASDAQ:ONC) vs. Aurora Cannabis (NASDAQ:ACB) - Daily Political

Cannabis Stocks To Research - October 13th - Daily Political

Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher

Top Cannabis Stocks To Add to Your Watchlist - October 10th - Stock Observer

Comparing Aurora Cannabis (NASDAQ:ACB) and ProPhase Labs (NASDAQ:PRPH)

Aurora Cannabis (TSE:ACB) Price Target Raised to C$7.00 - Zolmax

Aurora Cannabis (OTCMKTS:ACBFF) Stock Jumps 2.9% - Should You Buy? - Markets Daily

Promising Cannabis Stocks To Research - October 8th - Daily Political

Why Curaleaf Holdings (TSX:CURA) Is Getting Attention Today